Key result
LMWH replaces UFH for pregnancy VTE due to fewer side effects and easier administration.
Population
Pregnant women with deep venous thrombosis or pulmonary thromboembolism
Comparison
Low molecular weight heparins vs Unfractionated heparin
Design
Review
Authors
Loading...
May support LMWH preference for pregnancy VTE; leaves open need for RCTs on dosing and fetal outcomes.
Low molecular weight heparins are preferred over unfractionated heparin for managing venous thromboembolism in pregnancy due to better safety and convenience.
Ian A. Greer (2001) conducted a review in Venous thromboembolism in pregnancy. Low molecular weight heparins vs. Unfractionated heparin was evaluated. Low molecular weight heparins are replacing unfractionated heparin for treating venous thromboembolism in pregnancy due to a lower risk of side effects, ease of administration, and reduced monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: